🇺🇸 FDA
Patent

US 11628177

Compositions and methods for deep dermal drug delivery

granted A61KA61K31/519A61K31/585

Quick answer

US patent 11628177 (Compositions and methods for deep dermal drug delivery) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCUTIS BIOTHERAPEUTICS, INC.
Grant date
Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/519, A61K31/585, A61K47/20, A61K47/24